Skip to main content

梅毒テスト市場:将来の予測は印象的な成長率を示しています

 


Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results - thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.

The global syphilis testing market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the period 2014-2020. The secondary syphilis testing would continue to be the largest market segment through 2020.Latin America, Middle East & Africa (LAMEA) market accounted for about 43% revenue share of the syphilis testing market in 2014.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/675

LAMEA and Asia Pacificconstitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions.

The Major Key Players Are:

·        Roche Diagnostics

·        Hologic, Inc.

·        Becton Dickinson & Company

·        Abbott Laboratories

·        BioMerieux

·        Alere Inc.

·        Cepheid Inc.

·        Affymetrix, Inc.

·        Diasorin.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/675

Key findings of Syphilis Testing Market:

  • LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period
  • United states remains a major market in the North Americasyphilis testing market through 2020
  • Spainand Germanycollectively accounts for about one fourth of the Europesyphilis testing market
  • ChinaandIndiacollectively accounts for about 89% share in theAsia Pacificsyphilis testing market

Access Full Report @ https://www.alliedmarketresearch.com/syphilis-testing-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: 
https://www.alliedmarketresearch.com

Comments

Popular posts from this blog

ライフサイエンス試薬市場、トレンド、分析、機会、シェア、2019-2027年までの予測

  " Life Science Reagents Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report." Life Science Reagents Market Research has offered exhaustive analysis of Manufacturers, Suppliers, Regions, Type and Application, Forecast to 2027. And also provides essential study on the current status of the market, cover market size with respect to valuation as sales volume and providing a precise prediction of the market scenario over the forecast period from 2020 to 2027. Download Free Sample PDF@   https://www.alliedmarketresearch.com/request-sample/12658 The report provides revenue forecast with sales, sales growth rate, and revenue growth rate forecasts of the global  ...

ヘルスケア市場における人工知能(AI)to Reach $22.79 Bn, Globally, by 2023 at 48.7% CAGR

  Allied Market Research recently published a report, titled,   Artificial Intelligence in Healthcare Market  by Offering (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, and Payer): Global Opportunity Analysis and Industry Forecast, 2017 - 2023.   The report offers detailed analyses of the driving forces & opportunities, key market segments, top investment pockets, key market positioning, and competitive landscape. As per the report, the global AI in healthcare market generated $2.16 billion in 2017 and is expected to reach at   $22.79 billion   by 2023, ...

抗真菌薬市場 to Reach $17.72 Billion by 2023 at 3.7% CAGR

According to the report, the global Antifungal Drugs market generated $14.23 billion in 2017 and is estimated to reach $17.72 billion by 2023, growing at a CAGR of 3.7% from 2017 to 2023. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Favorable government funds to combat the antifungal diseases along with the increasing prevalence of fungal infection drive the growth of the market. Furthermore, rising awareness levels pertaining to myriad fungal infections supplement the market growth. However, the growing population with antifungal drug resistance and the presence of counterfeit drugs and side effects of antifungal drugs restrict the growth. On the other hand, patent expirations and increasing funding from public & private organizations offer lucrative opportunities for the market. Request Report Sample at:  https://www.alliedmarketresearch.com/request-sample/2370 B...